Abstract | PURPOSE OF REVIEW:
Hormone therapy increases the risk of venous thromboembolism (VTE). To reduce this risk, changes in dosage, composition and route of administration have been made over the years. This review provides a summary of the available evidence and an update on the most recent findings on the issue. RECENT FINDINGS: SUMMARY: Careful evaluation of individual risk factor is warranted before prescribing hormone therapy. Further investigations are needed to establish whether or not newer compounds are safer than older ones with respect to the risk of thrombosis.
|
Authors | Tullia Battaglioli, Ida Martinelli |
Journal | Current opinion in hematology
(Curr Opin Hematol)
Vol. 14
Issue 5
Pg. 488-93
(Sep 2007)
ISSN: 1065-6251 [Print] United States |
PMID | 17934355
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Drug-Related Side Effects and Adverse Reactions
- Estrogen Replacement Therapy
(adverse effects)
- Estrogens
(adverse effects, therapeutic use)
- Female
- Humans
- Postmenopause
(drug effects)
- Progestins
(adverse effects, therapeutic use)
- Risk Factors
- Thromboembolism
(chemically induced)
- Thrombophilia
(diagnosis)
- Venous Thrombosis
(chemically induced)
|